COM:EYEPOINTPHARMA
EyePoint Pharmaceuticals
- Stock
Last Close
8.35
22/11 21:00
Market Cap
452.61M
Beta: -
Volume Today
1.10M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Jun '14 | Jun '15 | Jun '16 | Jun '17 | Jun '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | -298.50K - | -311K 4.19% | -555K 78.46% | -369.50K 33.42% | -302K 18.27% | 892.50K 395.53% | 3.74M 318.77% | 4.48M 19.77% | 3.25M 27.38% | 3.40M 4.46% | |
average payables | 567.50K - | 604K 6.43% | 1.05M 74.42% | 1.19M 12.91% | 3.84M 222.78% | 9.02M 134.91% | 8.09M 10.27% | 6.10M 24.66% | 6.65M 9.08% | 6.21M 6.62% | |
average receivables | 557K - | 569.50K 2.24% | 555K 2.55% | 369.50K 33.42% | 302K 18.27% | 6.04M 1,898.84% | 10.59M 75.37% | 13.90M 31.33% | 16.93M 21.76% | 8.15M 51.83% | |
book value per share | 5.44 - | 7.95 46.27% | 6.60 16.99% | 3.77 42.86% | 2.53 33.00% | 0.80 68.41% | 1.44 80.88% | 6.41 343.87% | 2.58 59.72% | 6.85 165.09% | |
capex per share | -0.09 - | -0.05 39.35% | -0.04 34.80% | -0.04 16.39% | -0.02 43.83% | -0.02 12.60% | -0.03 38.11% | -0.01 80.77% | -0.06 962.10% | -0.09 55.39% | |
capex to depreciation | -0.27 - | -0.18 32.50% | -0.12 31.82% | -0.18 44.93% | -0.09 47.84% | -0.08 13.05% | -0.14 67.07% | -0.06 58.80% | -0.88 1,461.33% | -7.51 753.99% | |
capex to operating cash flow | 0.02 - | -0.02 167.28% | 0.01 144.29% | 0.01 3.59% | 0.00 31.28% | 0.00 23.80% | 0.03 567.56% | 0.00 87.58% | 0.03 962.13% | -1.86 5,716.43% | |
capex to revenue | -0.07 - | -0.01 91.51% | -0.07 1,050.93% | -0.02 72.05% | -0.04 87.06% | -0.01 71.32% | -0.01 0.51% | -0.00 59.82% | -0.05 1,129.58% | -0.08 45.76% | |
cash per share | 6.66 - | 9.71 45.84% | 9.17 5.61% | 4.78 47.85% | 8.39 75.45% | 2.13 74.61% | 3.50 64.29% | 7.36 110.27% | 3.87 47.34% | 8.51 119.66% | |
days of inventory on hand | 290.42 - | 334.48 15.17% | 161.41 51.74% | 126.52 21.62% | 307.79 143.28% | ||||||
days payables outstanding | 2.17K - | 1.55K - | 301.51 80.49% | 329.65 9.33% | 259.48 21.29% | 512.51 97.51% | |||||
days sales outstanding | 54.33 - | 8.55 84.27% | 109.95 1,186.54% | 12.15 88.95% | 43.51 258.08% | 210.06 382.73% | 100.19 52.30% | 181.36 81.01% | 136.67 24.64% | 6.39 95.33% | |
debt to assets | 0.24 - | 0.69 185.75% | 0.53 22.98% | 0.15 72.00% | 0.25 70.48% | 0.02 93.93% | |||||
debt to equity | 1.48 - | 6.07 310.16% | 2.63 56.72% | 0.21 91.91% | 0.47 123.37% | 0.02 95.68% | |||||
dividend yield | |||||||||||
earnings yield | -0.11 - | 0.06 151.11% | -0.24 520.14% | -0.31 27.03% | -0.55 80.81% | -0.39 29.57% | -0.62 60.06% | -0.18 70.87% | -0.95 425.02% | -0.08 91.52% | |
enterprise value | 103.77M - | 91.63M 11.70% | 74.18M 19.05% | 43.54M 41.30% | 74.68M 71.53% | 190.07M 154.50% | 79.86M 57.98% | 211.83M 165.25% | 80.75M 61.88% | 600.32M 643.48% | |
enterprise value over ebitda | -8.21 - | 14.27 273.90% | -3.41 123.87% | -2.34 31.20% | -2.85 21.74% | -4.29 50.20% | -2.30 46.41% | -4.03 75.60% | -1.08 73.22% | -8.20 659.31% | |
ev to operating cash flow | -9.72 - | 8.90 191.51% | -4.55 151.09% | -2.12 53.26% | -3.41 60.43% | -3.35 1.67% | -5.53 65.03% | -4.23 23.57% | -1.24 70.62% | 320.17 25,875.85% | |
ev to sales | 29.88 - | 3.45 88.46% | 45.79 1,227.47% | 5.78 87.39% | 25.22 336.72% | 9.33 63.00% | 2.32 75.15% | 5.73 147.29% | 1.95 65.99% | 13.05 568.93% | |
free cash flow per share | -3.98 - | 3.45 186.72% | -5.20 250.58% | -5.84 12.39% | -4.76 18.44% | -5.46 14.56% | -1.15 78.87% | -1.75 51.59% | -1.80 2.98% | -0.04 97.70% | |
free cash flow yield | -0.09 - | 0.09 199.83% | -0.18 300.59% | -0.34 86.00% | -0.23 32.94% | -0.35 53.74% | -0.18 50.23% | -0.14 18.51% | -0.51 260.15% | -0.00 99.64% | |
graham net net | 3.98 - | 6.70 68.47% | 5.81 13.31% | 3.29 43.42% | -4.57 238.96% | -3.16 30.92% | -1.44 54.31% | 5.15 457.24% | 1.97 61.69% | 6.29 218.78% | |
graham number | 24.40 - | 19.66 19.41% | 31.82 61.81% | 21.07 33.77% | 25.58 21.39% | 10.41 59.28% | 11.55 10.86% | 17.91 55.08% | 13.92 22.24% | 16.74 20.24% | |
income quality | 0.80 - | 1.62 103.04% | 0.76 53.32% | 1.11 46.38% | 0.41 62.83% | 1.00 142.31% | 0.32 68.15% | 0.86 169.68% | 0.64 25.87% | -0.03 104.17% | |
intangibles to total assets | 0.12 - | 0.06 51.24% | 0.03 41.40% | 0.02 44.08% | 0.44 2,145.00% | 0.38 13.75% | 0.27 27.16% | 0.09 68.57% | 0 100% | 0 | |
interest coverage | -13.49K - | -36.49 - | -7.75 78.76% | -5.14 33.69% | -10.05 95.66% | -24.75 146.21% | -59.07 138.64% | ||||
interest debt per share | 0.00 - | 3.90 - | 5.44 39.56% | 4.36 19.84% | 1.55 64.38% | 1.31 15.60% | 0.17 86.84% | ||||
inventory turnover | 1.26 - | 1.09 13.17% | 2.26 107.22% | 2.88 27.58% | 1.19 58.89% | ||||||
invested capital | 1.48 - | 6.07 310.16% | 2.63 56.72% | 0.21 91.91% | 0.47 123.37% | 0.02 95.68% | |||||
market cap | 119.11M - | 110.76M 7.01% | 89.49M 19.20% | 60.44M 32.47% | 96.15M 59.09% | 161.68M 68.15% | 84.46M 47.76% | 352.00M 316.76% | 130.61M 62.89% | 876.12M 570.79% | |
net current asset value | 11.60M - | 20.84M 79.72% | 19.23M 7.75% | 12.40M 35.51% | -20.07M 261.90% | -22.92M 14.20% | -10.06M 56.12% | 158.75M 1,678.38% | 88.82M 44.05% | 255.94M 188.15% | |
net debt to ebitda | 1.21 - | -2.98 345.57% | 0.70 123.62% | 0.91 29.35% | 0.82 9.84% | -0.64 178.05% | 0.13 120.68% | 2.67 1,916.43% | 0.67 75.01% | 3.77 464.87% | |
net income per share | -4.87 - | 2.16 144.40% | -6.81 415.38% | -5.23 23.24% | -11.50 119.93% | -6.04 47.52% | -4.10 32.05% | -2.22 45.82% | -3.34 50.13% | -1.82 45.46% | |
operating cash flow per share | -3.89 - | 3.51 190.14% | -5.16 247.20% | -5.80 12.36% | -4.74 18.25% | -5.44 14.70% | -1.12 79.31% | -1.74 54.91% | -1.74 0.00% | 0.05 102.77% | |
payables turnover | 0.17 - | 0.24 - | 1.21 412.52% | 1.11 8.53% | 1.41 27.04% | 0.71 49.37% | |||||
receivables turnover | 6.72 - | 42.71 535.78% | 3.32 92.23% | 30.04 804.78% | 8.39 72.07% | 1.74 79.28% | 3.64 109.65% | 2.01 44.75% | 2.67 32.70% | 57.17 2,040.45% | |
research and ddevelopement to revenue | 2.76 - | 0.46 83.49% | 8.88 1,850.87% | 1.97 77.77% | 5.46 176.82% | 0.75 86.19% | 0.51 32.95% | 0.77 52.49% | 1.20 55.40% | 1.40 16.65% | |
return on tangible assets | -0.67 - | 0.21 131.08% | -0.71 438.65% | -1.01 42.96% | -1.32 30.67% | -1.38 4.57% | -0.79 42.60% | -0.27 66.45% | -0.69 159.91% | -0.20 71.13% | |
revenue per share | 1.27 - | 9.04 614.55% | 0.51 94.33% | 2.13 316.38% | 0.64 69.97% | 1.95 204.79% | 2.68 37.42% | 1.28 52.12% | 1.11 13.62% | 1.18 6.61% | |
roe | -0.89 - | 0.27 130.35% | -1.03 479.92% | -1.39 34.33% | -4.55 228.23% | -7.56 66.15% | -2.84 62.43% | -0.35 87.79% | -1.29 272.73% | -0.27 79.43% | |
roic | -0.90 - | 0.27 130.24% | -1.04 482.48% | -1.33 28.61% | -0.47 64.66% | -0.85 80.98% | -0.62 27.05% | -0.27 56.82% | -0.65 141.90% | -0.27 58.93% | |
sales general and administrative to revenue | 2.15 - | 0.30 85.90% | 5.56 1,734.61% | 1.49 73.21% | 3.90 161.64% | 0.88 77.41% | 0.60 31.68% | 0.69 15.04% | 0.84 21.46% | 0.87 3.63% | |
shareholders equity per share | 5.44 - | 7.95 46.27% | 6.60 16.99% | 3.77 42.86% | 2.53 33.00% | 0.80 68.41% | 1.44 80.88% | 6.41 343.87% | 2.58 59.72% | 6.85 165.09% | |
stock based compensation to revenue | 0.41 - | 0.07 81.83% | 1.34 1,708.73% | 0.33 75.60% | 0.91 180.32% | 0.22 75.44% | 0.16 28.19% | 0.20 25.16% | 0.34 69.84% | 0.26 23.48% | |
tangible asset value | 12.16M - | 21.44M 76.35% | 19.78M 7.76% | 12.97M 34.42% | -19.67M 251.64% | -19.34M 1.69% | -6.67M 65.52% | 161.63M 2,523.98% | 96.37M 40.38% | 266.32M 176.36% | |
tangible book value per share | 4.43 - | 7.30 64.75% | 6.25 14.31% | 3.67 41.32% | -4.26 215.94% | -1.85 56.43% | -0.52 71.98% | 5.62 1,181.93% | 2.58 54.05% | 6.85 165.09% | |
working capital | 17.22M - | 26.49M 53.87% | 24.87M 6.12% | 12.45M 49.94% | 18.25M 46.55% | 30.20M 65.50% | 48.23M 59.72% | 214.09M 343.89% | 138.27M 35.41% | 281.54M 103.61% |
All numbers in USD (except ratios and percentages)